We are live on ! Find out more
ETRM

EnteroMedics Inc.
ETRM

Delisted

ETRM was delisted on the 20th of October, 2017.

Back to rankings

49 hedge funds and large institutions have $19.8M invested in EnteroMedics Inc. in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $667K | Put options by funds: $192K

25% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 12

13% less funds holding

Funds holding: 56 → 49 (-7)

16% less capital invested

Capital invested by funds: $23.5M → $19.8M (-$3.76M)

58% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 12

Holders
49
Holders Change
-7
Holders Change %
-12.5%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
15
Reduced
12
Closed
12
Calls
$667K
Puts
$192K
Net Calls
+$475K
Net Calls Change
-$928K

Top Buyers

Rank Fund Capital Flow
1
IHM
Iguana Healthcare Management
New York
+$2.43M
2
RSCM
Rock Springs Capital Management
Maryland
+$383K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$267K
4
FAM
Fred Alger Management
New York
+$236K
5
California Public Employees Retirement System
California Public Employees Retirement System
California
+$155K

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$575K
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$468K
3
AAP
Ardsley Advisory Partners
Connecticut
-$468K
4
SC
Sophrosyne Capital
New York
-$468K
5
TMC
Trellus Management Company
Florida
-$219K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
26
Rotella Capital Management
Washington
$33K -$60.1K -41 -62%
MAA
27
Managed Account Advisors
New Jersey
$30K -$2.93K -2 -8%
Group One Trading
28
Group One Trading
Illinois
$29K +$24.9K +17 +340%
ST
29
Spot Trading
Illinois
$22K – – –
Cambridge Investment Research Advisors
30
Cambridge Investment Research Advisors
Iowa
$19K +$2.93K +2 +15%
State Street
31
State Street
Massachusetts
$18K – – –
RNS
32
Robert N. Shapiro
$17K +$19.1K +13 New
BIM
33
BlackRock Investment Management
Delaware
$12K – – –
Citadel Advisors
34
Citadel Advisors
Florida
$7K -$2.93K -2 -29%
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
$7K – – –
Deutsche Bank
36
Deutsche Bank
Germany
$6K – – –
TRCT
37
Tower Research Capital (TRC)
New York
$4K -$1.47K -1 -25%
TWA
38
TCI Wealth Advisors
Arizona
$4K +$4.4K +3 New
LTFS
39
Ladenburg Thalmann Financial Services
Florida
$3K – – –
PFO
40
Pathstone Family Office
New Jersey
$3K – – –
U
41
UBS
Switzerland
$2K -$68.9K -47 -96%
Ameriprise
42
Ameriprise
Minnesota
$2K – – –
AIG
43
American International Group
New York
$1.23K – – –
Creative Planning
44
Creative Planning
Kansas
$1K -$2.93K -2 -67%
PRCM
45
Pine River Capital Management
Minnesota
$1K – – –
US Bancorp
46
US Bancorp
Minnesota
$1K – – –
Canada Life
47
Canada Life
Manitoba, Canada
$1K +$1.47K +1 New
Citigroup
48
Citigroup
New York
$1K +$1.47K +1 New
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3 – – –
Adage Capital Partners
50
Adage Capital Partners
Massachusetts
– -$468K -286 Closed
1
2
3

ETRM Hedge Fund Activity: Q3 2014 in Review

49 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q3 2014, worth a combined $19.8M — down 16% from $23.5M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ETRM and 5 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 15 added.

The largest buyer was Iguana Healthcare Management, adding an estimated $2.43M. The largest seller was Royce & Associates, cutting an estimated $575K.

  • 49 institutional investors held EnteroMedics Inc. (ETRM) as of Q3 2014, down from 56 in Q2 2014.
  • Funds reported $19.8M of EnteroMedics Inc. stock for Q3 2014, down 16% quarter-over-quarter.
  • 5 funds opened new EnteroMedics Inc. positions in Q3 2014 and 12 closed out, a net change of -7 holders.
  • The largest EnteroMedics Inc. buyer in Q3 2014 was Iguana Healthcare Management, an estimated $2.43M added.
  • The largest EnteroMedics Inc. seller in Q3 2014 was Royce & Associates, an estimated $575K sold.

Based on aggregated 13F filings for Q3 2014.